Hong Kong-listed Sisram Medical Ltd reported a stable capital structure for the month ended 31 August 2026.

• Authorised share capital remained at 1,000,000,000 ordinary shares with a par value of ILS 0.01, equivalent to ILS 10.00 million. No authorisations were added or cancelled during the period.

• Issued share capital was unchanged at 468.34 million ordinary shares. The company held no treasury shares at month-end, leaving total issued shares identical to the free-floating amount.

• Sisram Medical confirmed compliance with the Main Board’s minimum public-float requirement of 25 percent.

• The filing shows no movements in share options, warrants, convertibles, or any other equity-linked instruments, and no Hong Kong Depositary Receipt activity.

The disclosure indicates that Sisram Medical undertook no equity financing, buy-backs, or other capital events in August, maintaining a steady share base ahead of the next reporting period.